GDNF enhances human blood-nerve barrier function in vitro via MAPK signaling pathways

References

• Greathouse KM, Palladino SP, Dong C, Helton ES, Ubogu EE. Modeling leukocyte trafficking at the human blood-nerve barrier in vitro and in vivo geared towards targeted molecular therapies for peripheral neuroinflammation. J Neuroinflammation. 2016;13:3. doi:10.1186/s12974-015-0469-3.
   PubMed Web of Science ®Google Scholar
• Olsson Y. Microenvironment of the peripheral nervous system under normal and pathological conditions. Crit Rev Neurobiol. 1990;5:265–311.
   PubMed Web of Science ®Google Scholar
• Mizisin AP, Weerasuriya A. Homeostatic regulation of the endoneurial microenvironment during development, aging and in response to trauma, disease and toxic insult. Acta Neuropathol. 2011;121:291–312. doi:10.1007/s00401-010-0783-x.
   PubMed Web of Science ®Google Scholar
• Reina MA, Lopez A, Villanueva MC, De Andres JA, Maches F. [The blood-nerve barrier in peripheral nerves]. Rev Esp Anestesiol Reanim. 2003;50:80–86.
   PubMedGoogle Scholar
• Reina MA, Lopez A, Villanueva MC, de Andres JA, Leon GI. [Morphology of peripheral nerves, their sheaths, and their vascularization]. Rev Esp Anestesiol Reanim. 2000;47:464–475.
   PubMedGoogle Scholar
• Ubogu EE. The molecular and biophysical characterization of the human blood-nerve barrier: current concepts. J Vasc Res. 2013;50:289–303. doi:10.1159/000353293.
   PubMed Web of Science ®Google Scholar
• Palladino SP, Helton ES, Jain P, Dong C, Crowley MR, Crossman DK, Ubogu EE. The human blood-nerve barrier transcriptome. Sci Rep. 2017;7:17477. doi:10.1038/s41598-017-17475-y.
   PubMed Web of Science ®Google Scholar
• Beck KD, Valverde J, Alexi T, Poulsen K, Moffat B, Vandlen RA, Rosenthal A, Hefti F. Mesencephalic dopaminergic neurons protected by GDNF from axotomy-induced degeneration in the adult brain. Nature. 1995;373:339–341. doi:10.1038/373339a0.
   PubMed Web of Science ®Google Scholar
• Bennett DL, Michael GJ, Ramachandran N, Munson JB, Averill S, Yan Q, McMahon SB, Priestley JV. A distinct subgroup of small DRG cells express GDNF receptor components and GDNF is protective for these neurons after nerve injury. J Neurosci. 1998;18:3059–3072.
   PubMed Web of Science ®Google Scholar
• Henderson CE, Phillips HS, Pollock RA, Davies AM, Lemeulle C, Armanini M, Simmons L, Moffet B, Vandlen RA, Simpson LC Corrected to Simmons L, et al. GDNF: a potent survival factor for motoneurons present in peripheral nerve and muscle. Science. 1994;266:1062–1064.
   PubMed Web of Science ®Google Scholar
• Takahashi M. The GDNF/RET signaling pathway and human diseases. Cytokine Growth Factor Rev. 2001;12:361–373.
   PubMed Web of Science ®Google Scholar
• Trupp M, Ryden M, Jornvall H, Funakoshi H, Timmusk T, Arenas E, Ibanez CF. Peripheral expression and biological activities of GDNF, a new neurotrophic factor for avian and mammalian peripheral neurons. J Cell Biol. 1995;130:137–148.
   PubMed Web of Science ®Google Scholar
• Airaksinen MS, Saarma M. The GDNF family: signalling, biological functions and therapeutic value. Nat Rev Neurosci. 2002;3:383–394. doi:10.1038/nrn812.
   PubMed Web of Science ®Google Scholar
• Jing S, Wen D, Yu Y, Holst PL, Luo Y, Fang M, Tamir R, Antonio L, Hu Z, Cupples R, et al. GDNF-induced activation of the ret protein tyrosine kinase is mediated by GDNFR-alpha, a novel receptor for GDNF. Cell. 1996;85:1113–1124.
   PubMed Web of Science ®Google Scholar
• Ibanez CF. Structure and physiology of the RET receptor tyrosine kinase. Cold Spring Harb Perspect Biol. 2013;5. doi:10.1101/cshperspect.a009134.
   PubMed Web of Science ®Google Scholar
• Ibanez CF, Andressoo JO. Biology of GDNF and its receptors - Relevance for disorders of the central nervous system. Neurobiol Dis. 2017;97:80–89. doi:10.1016/j.nbd.2016.01.021.
   PubMed Web of Science ®Google Scholar
• Allen SJ, Watson JJ, Shoemark DK, Barua NU, Patel NK. GDNF, NGF and BDNF as therapeutic options for neurodegeneration. Pharmacol Ther. 2013;138:155–175. doi:10.1016/j.pharmthera.2013.01.004.
   PubMed Web of Science ®Google Scholar
• Reddy CL, Yosef N, Ubogu EE. VEGF-A165 potently induces human blood-nerve barrier endothelial cell proliferation, angiogenesis, and wound healing in vitro. Cell Mol Neurobiol. 2013;33:789–801. doi:10.1007/s10571-013-9946-3.
   PubMed Web of Science ®Google Scholar
• Yosef N, Ubogu EE. GDNF restores human blood-nerve barrier function via RET tyrosine kinase-mediated cytoskeletal reorganization. Microvasc Res. 2012;83:298–310. doi:10.1016/j.mvr.2012.01.005.
   PubMed Web of Science ®Google Scholar
• Shimizu F, Sano Y, Saito K, Abe M-A, Maeda T, Haruki H, Kanda T. Pericyte-derived glial cell line-derived neurotrophic factor increase the expression of claudin-5 in the blood-brain barrier and the blood-nerve barrier. Neurochem Res. 2012;37:401–409. doi:10.1007/s11064-011-0626-8.
   PubMed Web of Science ®Google Scholar
• Ubogu EE. Translational strategies in peripheral neuroinflammation and neurovascular repair. Transl Neurosci. 2012;3:373–383. doi:10.2478/s13380-012-0039-4.
   PubMed Web of Science ®Google Scholar
• Igarashi Y, Chiba H, Utsumi H, Miyajima H, Ishizaki T, Gotoh T, Kuwahara K, Tobioka H, Satoh M, Mori M, et al. Expression of receptors for glial cell line-derived neurotrophic factor (GDNF) and neurturin in the inner blood-retinal barrier of rats. Cell Struct Funct. 2000;25:237–241.
   PubMed Web of Science ®Google Scholar
• Igarashi Y, Utsumi H, Chiba H, Yamada-Sasamori Y, Tobioka H, Kamimura Y, Furuuchi K, Kokai Y, Nakagawa T, Mori M, et al. Glial cell line-derived neurotrophic factor induces barrier function of endothelial cells forming the blood-brain barrier. Biochem Biophys Res Commun. 1999;261:108–112. doi:10.1006/bbrc.1999.0992.
   PubMed Web of Science ®Google Scholar
• Kamimura Y, Chiba H, Utsumi H, Gotoh T, Tobioka H, Sawada N. Barrier function of microvessels and roles of glial cell line-derived neurotrophic factor in the rat testis. Med Electron Microsc. 2002;35:139–145. doi:10.1007/s007950200017.
   PubMedGoogle Scholar
• Meir M, Flemming S, Burkard N, Bergauer L, Metzger M, Germer C-T, Schlegel N. Glial cell line-derived neurotrophic factor promotes barrier maturation and wound healing in intestinal epithelial cells in vitro. Am J Physiol Gastrointest Liver Physiol. 2015;309:G613–24. doi:10.1152/ajpgi.00357.2014.
   PubMed Web of Science ®Google Scholar
• Brun P, Giron MC, Qesari M, Porzionato A, Caputi V, Zoppellaro C, Banzato S, Grillo AR, Spagnol L, De Caro R, et al. Toll-like receptor 2 regulates intestinal inflammation by controlling integrity of the enteric nervous system. Gastroenterology. 2013;145:1323–1333. doi:10.1053/j.gastro.2013.08.047.
   PubMed Web of Science ®Google Scholar
• Steinkamp M, Geerling I, Seufferlein T, von Boyen G, Egger B, Grossmann J, Ludwig L, Adler G, Reinshagen M. Glial-derived neurotrophic factor regulates apoptosis in colonic epithelial cells. Gastroenterology. 2003;124:1748–1757.
   PubMed Web of Science ®Google Scholar
• Meir M, Flemming S, Burkard N, Wagner J, Germer C-T, Schlegel N. The glial cell-line derived neurotrophic factor: a novel regulator of intestinal barrier function in health and disease. Am J Physiol Gastrointest Liver Physiol. 2016;310:G1118–23. doi:10.1152/ajpgi.00125.2016.
   PubMed Web of Science ®Google Scholar
• Szulcek R, Bogaard HJ, van Nieuw Amerongen GP. Electric cell-substrate impedance sensing for the quantification of endothelial proliferation, barrier function, and motility. J Vis Exp. 2014. doi:10.3791/51300.
   PubMed Web of Science ®Google Scholar
• Glass R, Loesch A, Bodin P, Burnstock G. P2X4 and P2X6 receptors associate with VE-cadherin in human endothelial cells. Cell Mol Life Sci. 2002;59:870–881.
   PubMed Web of Science ®Google Scholar
• Sauteur L, Affolter M, Belting HG. Distinct and redundant functions of Esama and VE-cadherin during vascular morphogenesis. Development. 2017;144:1554–1565. doi:10.1242/dev.140038.
   PubMed Web of Science ®Google Scholar
• Hartsock A, Nelson WJ. Adherens and tight junctions: structure, function and connections to the actin cytoskeleton. Biochim Biophys Acta. 2008;1778:660–669. doi:10.1016/j.bbamem.2007.07.012.
   PubMed Web of Science ®Google Scholar
• Zihni C, Mills C, Matter K, Balda MS. Tight junctions: from simple barriers to multifunctional molecular gates. Nat Rev Mol Cell Biol. 2016;17:564–580. doi:10.1038/nrm.2016.80.
   PubMed Web of Science ®Google Scholar
• Stamatovic SM, Johnson AM, Keep RF, Andjelkovic AV. Junctional proteins of the blood-brain barrier: new insights into function and dysfunction. Tissue Barriers. 2016;4:e1154641. doi:10.1080/21688370.2016.1154641.
   PubMed Web of Science ®Google Scholar
• Cerutti C, Ridley AJ. Endothelial cell-cell adhesion and signaling. Exp Cell Res. 2017;358:31–38. doi:10.1016/j.yexcr.2017.06.003.
   PubMed Web of Science ®Google Scholar
• Sluysmans S, Vasileva E, Spadaro D, Shah J, Rouaud F, Citi S. The role of apical cell-cell junctions and associated cytoskeleton in mechanotransduction. Biol Cell. 2017;109:139–161. doi:10.1111/boc.201600075.
   PubMed Web of Science ®Google Scholar
• Yosef N, Ubogu EE. An immortalized human blood-nerve barrier endothelial cell line for in vitro permeability studies. Cell Mol Neurobiol. 2013;33:175–186. doi:10.1007/s10571-012-9882-7.
   PubMed Web of Science ®Google Scholar
• Liebner S, Czupalla CJ, Wolburg H. Current concepts of blood-brain barrier development. Int J Dev Biol. 2011;55:467–476. doi:10.1387/ijdb.103224sl.
   PubMed Web of Science ®Google Scholar
• Menezes MJ, McClenahan FK, Leiton CV, Aranmolate A, Shan X, Colognato H. The extracellular matrix protein laminin alpha2 regulates the maturation and function of the blood-brain barrier. J Neurosci. 2014;34:15260–15280. doi:10.1523/JNEUROSCI.3678-13.2014.
   PubMed Web of Science ®Google Scholar
• Zobel K, Hansen U, Galla HJ. Blood-brain barrier properties in vitro depend on composition and assembly of endogenous extracellular matrices. Cell Tissue Res. 2016;365:233–245. doi:10.1007/s00441-016-2397-7.
   PubMed Web of Science ®Google Scholar
• Santaguida S, Janigro D, Hossain M, Oby E, Rapp E, Cucullo L. Side by side comparison between dynamic versus static models of blood-brain barrier in vitro: a permeability study. Brain Res. 2006;1109:1–13. doi:10.1016/j.brainres.2006.06.027.
   PubMed Web of Science ®Google Scholar
• Shimizu F, Sano Y, Abe M-A, Maeda T, Ohtsuki S, Terasaki T, Kanda T. Peripheral nerve pericytes modify the blood-nerve barrier function and tight junctional molecules through the secretion of various soluble factors. J Cell Physiol. 2011;226:255–266. doi:10.1002/jcp.22337.
   PubMed Web of Science ®Google Scholar
• Appelt-Menzel A, Cubukova A, Günther K, Edenhofer F, Piontek J, Krause G, Stüber T, Walles H, Neuhaus W, Metzger M. Establishment of a human blood-brain barrier co-culture model mimicking the neurovascular unit using induced pluri- and multipotent stem cells. Stem Cell Rep. 2017;8:894–906. doi:10.1016/j.stemcr.2017.02.021.
   PubMed Web of Science ®Google Scholar
• Wang YI, Abaci HE, Shuler ML. Microfluidic blood-brain barrier model provides in vivo-like barrier properties for drug permeability screening. Biotechnol Bioeng. 2017;114:184–194. doi:10.1002/bit.26045.
   PubMed Web of Science ®Google Scholar
• Dejana E, Orsenigo F, Molendini C, Baluk P, McDonald DM. Organization and signaling of endothelial cell-to-cell junctions in various regions of the blood and lymphatic vascular trees. Cell Tissue Res. 2009;335:17–25. doi:10.1007/s00441-008-0694-5.
   PubMed Web of Science ®Google Scholar
• Norris WD, Steele JG, Johnson G, Underwood PA. Serum enhancement of human endothelial cell attachment to and spreading on collagens I and IV does not require serum fibronectin or vitronectin. J Cell Sci. 1990;95(Pt 2):255–262.
   PubMedGoogle Scholar
• Qian T, Maguire SE, Canfield SG, Bao X, Olson WR, Shusta EV, Palecek SP. Directed differentiation of human pluripotent stem cells to blood-brain barrier endothelial cells. Sci Adv. 2017;3:e1701679. doi:10.1126/sciadv.1701679.
   PubMed Web of Science ®Google Scholar
• Dong C, Greathouse KM, Beacham RL, Palladino SP, Helton ES, Ubogu EE. Fibronectin connecting segment-1 peptide inhibits pathogenic leukocyte trafficking and inflammatory demyelination in experimental models of chronic inflammatory demyelinating polyradiculoneuropathy. Exp Neurol. 2017;292:35–45. doi:10.1016/j.expneurol.2017.02.012.
   PubMed Web of Science ®Google Scholar
• Dong C, Palladino SP, Helton ES, Ubogu EE. The pathogenic relevance of alphaM-integrin in Guillain-Barre syndrome. Acta Neuropathol. 2016;132:739–752. doi:10.1007/s00401-016-1599-0.
   PubMed Web of Science ®Google Scholar
• Schneider C, King RM, Philipson L. Genes specifically expressed at growth arrest of mammalian cells. Cell. 1988;54:787–793.
   PubMed Web of Science ®Google Scholar
• Nelson PJ, Daniel TO. Emerging targets: molecular mechanisms of cell contact-mediated growth control. Kidney Int. 2002;61:S99–105. doi:10.1046/j.1523-1755.2002.0610s1099.x.
   PubMedGoogle Scholar
• Nighot PK, Hu CA, Ma TY. Autophagy enhances intestinal epithelial tight junction barrier function by targeting claudin-2 protein degradation. J Biol Chem. 2015;290:7234–7246. doi:10.1074/jbc.M114.597492.
   PubMed Web of Science ®Google Scholar
• Naveilhan P, ElShamy WM, Ernfors P. Differential regulation of mRNAs for GDNF and its receptors Ret and GDNFR alpha after sciatic nerve lesion in the mouse. Eur J Neurosci. 1997;9:1450–1460.
   PubMed Web of Science ®Google Scholar
• Xu P, Rosen KM, Hedstrom K, Rey O, Guha S, Hart C, Corfas G. Nerve injury induces glial cell line-derived neurotrophic factor (GDNF) expression in Schwann cells through purinergic signaling and the PKC-PKD pathway. Glia. 2013;61:1029–1040. doi:10.1002/glia.22491.
   PubMed Web of Science ®Google Scholar
• Dong C, Helton ES, Zhou P, Ouyang X, d’Anglemont de Tassigny X, Pascual A, López-Barneo J, Ubogu EE. Glial-derived neurotrophic factor is essential for blood-nerve barrier functional recovery in an experimental murine model of traumatic peripheral neuropathy. Tissue Barriers. 2018;6:1–22. doi:10.1080/21688370.2018.1479570.
   Web of Science ®Google Scholar
• Ee X, Yan Y, Hunter DA, Schellhardt L, Sakiyama-Elbert SE, Mackinnon SE, Wood MD. Transgenic SCs expressing GDNF-IRES-DsRed impair nerve regeneration within acellular nerve allografts. Biotechnol Bioeng. 2017;114:2121–2130. doi:10.1002/bit.26335.
   PubMed Web of Science ®Google Scholar
• Wood MD, Gordon T, Kemp SW, Liu EH, Kim H, Shoichet MS, Borschel GH. Functional motor recovery is improved due to local placement of GDNF microspheres after delayed nerve repair. Biotechnol Bioeng. 2013;110:1272–1281. doi:10.1002/bit.24800.
   PubMed Web of Science ®Google Scholar
• Santosa KB, Jesuraj NJ, Viader A, MacEwan M, Newton P, Hunter DA, Mackinnon SE, Johnson PJ. Nerve allografts supplemented with schwann cells overexpressing glial-cell-line-derived neurotrophic factor. Muscle Nerve. 2013;47:213–223. doi:10.1002/mus.v47.2.
   PubMed Web of Science ®Google Scholar
• Yosef N, Xia RH, Ubogu EE. Development and characterization of a novel human in vitro blood-nerve barrier model using primary endoneurial endothelial cells. J Neuropathol Exp Neurol. 2010;69:82–97. doi:10.1097/NEN.0b013e3181c84a9a.
   PubMed Web of Science ®Google Scholar
• Yosef N, Ubogu EE. alpha(M)beta(2)-integrin-intercellular adhesion molecule-1 interactions drive the flow-dependent trafficking of Guillain-Barre syndrome patient derived mononuclear leukocytes at the blood-nerve barrier in vitro. J Cell Physiol. 2012;227:3857–3875. doi:10.1002/jcp.24100.
   PubMed Web of Science ®Google Scholar
• Ma C, Kojima K, Xu N, Mobley J, Zhou L, Yang S-T, Liu XM. Comparative proteomics analysis of high n-butanol producing metabolically engineered Clostridium tyrobutyricum. J Biotechnol. 2015;193:108–119. doi:10.1016/j.jbiotec.2014.10.036.
   PubMed Web of Science ®Google Scholar
• Helton ES, Palladino S, Ubogu EE. A novel method for measuring hydraulic conductivity at the human blood-nerve barrier in vitro. Microvasc Res. 2017;109:1–6. doi:10.1016/j.mvr.2016.08.005.
   PubMed Web of Science ®Google Scholar